Country: Israel
Language: English
Source: Ministry of Health
SODIUM CHLORIDE
A.L. MEDI-MARKET LTD.
B05CB01
SOLUTION FOR INFUSION
SODIUM CHLORIDE 9 MG/ML
I.V
Required
IMUNA PHARM A.S, SLOVAK REPUBLIC
SODIUM CHLORIDE
Short- term intravascular volume substitution. Hypotonic dehydration or isotonic dehydration. Vehicle solution for supplementary medication.Fluid and electrolyte replacement, hypochloremic alkalosis and chloride losses.
2021-06-20
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Sodium chloride 0.9% Imuna 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1000 mL solution for infusion contain: Sodium chloride 9.0 g _Electrolytes_ Sodium 154 mmol/L Chloride 154 mmol/L For the full list of excipients, see section 6.1. 2. PHARMACEUTICAL FORM Solution for infusion Clear, colourless, solution free of mechanical impurities Theoretical osmolarity 308 mOsm/L Titration acidity (pH 7.4) < 0.3 mmol/L pH 4.5 – 7.0 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Short- term intravascular volume substitution. Hypotonic dehydration or isotonic dehydration. Vehicle solution for supplementary medication. Fluid and electrolyte replacement, hypochloremic alkalosis and chloride losses. 4.2 Posology and method of administration Dosage The dosage guideline for adults: Average dose: 1000 ml per day. Flow rate: Up to 180 drops/min, corresponding to 550 ml/h. Maximum recommended dosage: 40 ml per KG body weight and per day, not more than 2000 ml per day. Dosage is dependent upon the age, weight and clinical condition of the patient as well as laboratory determination. Route of administration I.V. 4.3 Contraindications Sodium chloride 0.9 % Imuna may not be used in the event of - hyperhydration - severe hypernatraemia. - severe hyperchloraemia 4.4 Special warnings and precautions for use Sodium chloride 0.9 % Imuna should be used with caution only in - hypokalaemia - hypernatraemia - hyperchloraemia - Conditions requiring a restricted intake of sodium, such as heart failure, generalised oedema, pulmonary oedema, hypertension, eclampsia and severe renal failure. In order to prevent osmotic demyelination syndrome from developing, serum sodium concentrations should not exceed 9 mmol/L/day. As a general recommendation, a rate of correction of 4 to 6 mmol/L/day is considered appropriate in the majority of cases, depending on the patient's conditions and associated risk factors. Clinical monitoring should include checks of the serum ionogram, water bala Read the complete document